ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures

March 29, 1985

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

NCI to Host SBIR Investor Forum

November 7, 2014

NIH Accepting FIRST Applications

May 2, 1986

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

National Dialogue plans biospecimen network

July 18, 2003